Cleared Traditional

K912239 - VZVSCAN(TM) LATEX AGGUTINATION TEST (FDA 510(k) Clearance)

Jun 1991
Decision
21d
Days
Class 2
Risk

K912239 is an FDA 510(k) clearance for the VZVSCAN(TM) LATEX AGGUTINATION TEST. This device is classified as a Antigen, Cf, (including Cf Control), Varicella-zoster (Class II - Special Controls, product code GQW).

Submitted by Bd Becton Dickinson Vacutainer Systems Preanalytic (Franklin Lakes, US). The FDA issued a Cleared decision on June 11, 1991, 21 days after receiving the submission on May 21, 1991.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3900.

Submission Details

510(k) Number K912239 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 21, 1991
Decision Date June 11, 1991
Days to Decision 21 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement

Device Classification

Product Code GQW — Antigen, Cf, (including Cf Control), Varicella-zoster
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3900